Head-to-head for women
CoreAge Rx vs Henry Meds
CoreAge Rx and Henry Meds both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
CoreAge Rx
Higher scoreMetabolic-Fit 86/100 · Grade B
Metabolic-Fit / 100
Best for: Someone considering both compounded injection options who wants an advertised flat price without a required subscription and will confirm the exact prescription, state access and refund terms.
Visit CoreAge RxHenry Meds
Metabolic-Fit 81/100 · Grade B−
Metabolic-Fit / 100
Best for: Someone comfortable with the stated plan commitment who confirms the full prescribed treatment cost before paying.
Visit Henry MedsThe verdict for women
CoreAge Rx edges out Henry Meds on the Metabolic-Fit Score, 86 to 81 (B vs B−). Someone considering both compounded injection options who wants an advertised flat price without a required subscription and will confirm the exact prescription, state access and refund terms.
Henry Meds is still a genuine option — semaglutide: $297/mo; tirzepatide: Oral: $891 prepaid for a listed 3-month supply; injection price unconfirmed. The oral tirzepatide section lists a three-month supply at $891 paid in full, but its delivery text conflicts on duration; injectable tirzepatide pricing needs confirmation. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
Price highlights compare average monthly budgets, using 52 weeks ÷ 12 months for weekly cycles. Quoted charges retain their billing units; unknown periods and fee-only or prepaid quotes do not compete.
| Detail | CoreAge Rx | Henry Meds |
|---|---|---|
| Metabolic-Fit Score | 86/100 · B | 81/100 · B− |
| Overall rank | #1 | #7 |
| Semaglutide | $79/mo advertised flat price; confirm prescription quantity and total | $297/mo |
| Tirzepatide | $129/mo advertised flat price; confirm prescription quantity and total | Oral: $891 prepaid for a listed 3-month supply; injection price unconfirmed |
| Coverage | US service; state restrictions vary by therapy — confirm during intake | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
The decision beyond the score
Compare the same medication and delivery form
Henry Meds lists compounded semaglutide injections at $297 monthly. CoreAge's current public offer advertises flat monthly prices of $79 for semaglutide and $129 for tirzepatide across doses, with no membership fee. Confirm the prescribed quantity, total due and repurchase terms; this public offer is not a personally verified checkout. Obtain an injection quote from each service for the prescribed supply and follow-up arrangement. Henry's longer plans have a separate commitment and should not replace its ordinary monthly option in a flexible-plan quote. Both involve a prescription decision, and the advertised payment does not establish which clinical plan is appropriate for you. Ask who reviews a change in symptoms, how dose adjustments are requested and whether additional charges appear. Ask those questions about the actual injection plan rather than comparing one company's injection with another company's tablet.
Henry also lists semaglutide at $247 per month when six months are paid in full, totaling $1,482, and $197 on a twelve-month plan totaling $2,364. Those are prepaid equivalents, not the $297 monthly option. Evaluate a prepaid equivalent against the amount committed and CoreAge's selected purchase terms, rather than treating every displayed monthly unit as the same obligation. Someone already satisfied with Henry's prescriber relationship should weigh continuity and the practical work of transferring care. The work of transferring records and arranging follow-up also belongs in the decision.
Henry's oral menu does not establish an injection comparison
The tirzepatide comparison has a more basic limitation. Henry's current public material establishes an oral offer of $891 paid in full for a listed three-month supply, with conflicting duration language elsewhere in that section. It does not establish a current injectable tirzepatide rate. Dividing $891 into three payments produces an equivalent for the advertised oral supply; it does not create an injectable subscription or resolve the fulfillment conflict. Obtain the prescribed form, amount supplied and delivery schedule in writing before using that offer in a budget.
Henry's semaglutide tablet menu is also separate: a standard sublingual program is listed at $249 and a lower-dose tablet or drop program at $179. A compounded oral formulation should not be treated as interchangeable with an approved finished tablet or the injection used in a clinical study. CoreAge's listed programs do not supply that oral choice. Both are general services rather than dedicated postpartum practices. CoreAge is a featured partner. The useful dividing line is the requested injection or oral formulation and its confirmed terms; the price of one form cannot establish the cost or suitability of another.
Based on the public terms documented in the CoreAge Rx review and Henry Meds review. Each review details the prices and terms. Confirm current terms before paying.
Metabolic-Fit / 100
CoreAge Rx
Metabolic-Fit 86/100 · Grade B
What we like
- Officially linked public offer advertises $79/month semaglutide and $129/month tirzepatide across doses
- Advertises care and free overnight cold shipping within those prices, with no membership fee
- Public offer describes one-time purchases, no required subscription and the same refill price
The caveats
- Main navigation still shows semaglutide from $99, conflicting with the $79 officially linked offer
- A patient-specific prescription quantity and checkout total were not verified; confirm before paying
- State eligibility depends on therapy; nationwide access should not be assumed
Metabolic-Fit / 100
Henry Meds
Metabolic-Fit 81/100 · Grade B−
What we like
- An established operator with a long, visible track record
- Some states allow an independent provider review without a scheduled video call
- Semaglutide: $297/mo; tirzepatide: Oral: $891 prepaid for a listed 3-month supply; injection price unconfirmed.
The caveats
- Compounded only, and no pregnancy or postpartum framing
- The oral tirzepatide section lists a three-month supply at $891 paid in full, but its delivery text conflicts on duration; injectable tirzepatide pricing needs confirmation.
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Comparisons close to CoreAge Rx vs Henry Meds.
- CoreAge Rx vs Direct Meds
- CoreAge Rx vs Pallas Health
- CoreAge Rx vs Found Health
- CoreAge Rx vs He and She MD
- Brightmeds vs EverSlim
- CoreAge Rx vs SynergyRX
Or browse the full comparison hub.